Berlimatoxumab

Product Name
Berlimatoxumab
CAS No.
1939109-24-6
Chemical Name
Berlimatoxumab
Synonyms
Berlimatoxumab;Research Grade Berlimatoxumab;Research Grade Berlimatoxumab (DXX00801)
CBNumber
CB88081052
Formula Weight
0
MOL File
Mol file
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

Berlimatoxumab Chemical Properties,Usage,Production

Uses

Berlimatoxumab (ASN-2) is an antibody. Berlimatoxumab can be used for experiment research.

Berlimatoxumab Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Berlimatoxumab Suppliers

China 15 Global 15
ShangHai Biochempartner Co.,Ltd
Tel
177-54423994 17754423994
Fax
QQ:2853530913
Email
2853530910@QQ.com
Country
China
ProdList
7999
Advantage
62
Guangzhou Hongyuan Chemical Co.,Ltd
Tel
15817493340
Email
981810490@qq.com
Country
China
ProdList
1566
Advantage
58
Wuhan Chemstan Biotechnology Co., Ltd.
Tel
027-65317797 15926423062
Fax
QQ：422450190
Email
422450190@qq.com
Country
China
ProdList
10308
Advantage
58
Biolab Reagents
Tel
027-65279366 18108604356
Email
products@biolabreagent.com
Country
China
ProdList
9866
Advantage
58
Wuhan Jingkangen Biomedical Technology Co., Ltd
Tel
13720134139 086-15871494362 13720134139
Email
orders@jknbiochem.com
Country
China
ProdList
7062
Advantage
58
Shanghai Yifei Biotechnology Co. , Ltd.
Tel
021-65675885 18964387627
Email
customer_service@efebio.com
Country
China
ProdList
11972
Advantage
58
Wuhan Acumen Bio-Technology Co.,ltd
Tel
027-027-16602739303 16602739303
Email
673003916@qq.com
Country
China
ProdList
4117
Advantage
58
Changsha Fuzhen Biotechnology Co.，LTD
Tel
18229892877 13823398779
Email
3062105966@qq.com
Country
China
ProdList
5353
Advantage
58
Olix (Shanghai) Pharmaceutical Technology Co., Ltd
Tel
17316404525 17316404525
Email
209533805@qq.com
Country
China
ProdList
9798
Advantage
58
Wanxin Biotechnology (Jiaxing) Co., LTD
Tel
0573-83568680 18057391398
Email
3956524501@qq.com
Country
China
ProdList
1442
Advantage
58

1939109-24-6, BerlimatoxumabRelated Search:

Detumomab Altumomab Research Grade Imdevimab (DVV00305) Vonlerolizumab Pasotuxizumab Pozelimab Lorigerlimab Suptavumab Quisovalimab Coprelotamab

  • Berlimatoxumab
  • Research Grade Berlimatoxumab (DXX00801)
  • Research Grade Berlimatoxumab
  • 1939109-24-6